Top Stock Picks from Analysts

Results

16

1 new

Companies which are more than 50% undervalued based on analyst price target.

16 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
HUBN
New
CHF 161.80-20.5%49.8%CHF 3.0bCHF 261.5041.037.2%1.2%Capital Goods
CMHC
CHF 58.302.1%0%CHF 1.0bCHF 122.5710.455.1%3.4%Pharmaceuticals & Biotech
NEAG
CHF 30.10-0.3%-10.9%CHF 994.3mCHF 60.006.5-14.1%3.0%Utilities
KURN
CHF 21.16-1.1%-18.2%CHF 839.5mCHF 33.92117.558.6%n/aPharmaceuticals & Biotech
MEDX
CHF 8.66-4.3%-21.1%CHF 352.5mCHF 14.973525.264.6%1.2%Healthcare
MIKN
CHF 16.15-3.0%-12.7%CHF 278.7mCHF 29.809.6-1.0%3.7%Capital Goods
NWRN
CHF 12.20-4.2%42.0%CHF 260.9mCHF 47.4814.250.2%n/aPharmaceuticals & Biotech
SANN
CHF 15.980.5%14.6%CHF 253.7mCHF 27.503.218.6%n/aPharmaceuticals & Biotech
PEAN
CHF 4.51-8.8%-32.5%CHF 250.9mCHF 7.871.8104.4%0%Real Estate Management and Development
BIOV
CHF 24.80-6.4%-0.4%CHF 145.5mCHF 58.2645.8-14.2%n/aPharmaceuticals & Biotech
VARN
CHF 13.10-1.5%-32.3%CHF 132.7mCHF 25.181.57.0%0%Real Estate Management and Development
MOLN
CHF 3.533.8%21.3%CHF 132.4mCHF 9.001.916.7%n/aPharmaceuticals & Biotech
LMN
CHF 11.75-4.9%-21.7%CHF 124.6mCHF 19.3740.460.9%3.3%Consumer Services
XLS
CHF 14.70-8.7%-29.3%CHF 86.7mCHF 31.00304.5-6.9%n/aPharmaceuticals & Biotech
MMTX
CHF 0.17-26.7%n/aCHF 25.5mCHF 2.7339.687.7%n/aPharmaceuticals & Biotech
ASWN
CHF 0.602.6%-42.9%CHF 8.7mCHF 2.000.583.7%n/aMedia
Page 1 of 1